Download PDF

Other users also viewed these articles

Recommendations for vaccination in patients with multiple sclerosis who are eligible for immunosuppressive therapies: Spanish consensus statement S. Otero-Romero; J. Rodríguez-García; A. Vilella; J.R. Ara; L. Brieva; C. Calles; O. Carmona; V. Casanova; L. Costa-Frossard; S. Eichau; J.A. García-Merino; C. Garcia-Vidal; M. González-Platas; M. Llaneza; M. Martínez-Ginés; J.E. Meca-Lallana; J.M. Prieto; A. Rodríguez-Antigüedad; M. Tintoré; Y. Blanco; E. Moral;
Neurologia. 2021;36:50-60
Multiple sclerosis mortality trends by sex in Chile, 1997¿2019 J. Arriagada Opazo; V. Farah González; M. González Delgadillo; L. Núñez-Franz; C. Morales Garcia; P. Jiménez Rodríguez;
Neurologia. 2025;40:840-8
Recommendations for the critical reading of clinical trials on disease-modifying drugs for multiple sclerosis A. Rivero-de-Aguilar; M. Mascareñas-García; M. Pérez-Ríos; M.A. Llaneza-Gonzalez; P. Mulero; M. Mendibe; À. Rovira; V. Meca-Lallana; A.J. García-Ruiz; L. Landete; J.R. Vizoso Hermida; P. Carrascal Rueda; A. Ruano-Raviña; M. Puente-Hernandez; L. Varela-Lema;
Neurologia. 2025;40:875-83